3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Medulloblastoma
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Brain Neoplasms
2
Xanthomatosis, Cerebrotendinous
1
Oligodendroglioma
1
Melanoma
1
Influenza, Human
1
Advanced Fallopian Tube Carcinoma
1
Interventions
Radiosurgery
51
Magnetic Resonance Spectroscopy
34
Temozolomide
28
Bevacizumab
24
pembrolizumab
23
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
Blood Specimen Collection
9
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Diphtheria-Tetanus Vaccine
×
1 year
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled